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Abstract
The membrane scission event that separates nascent enveloped virions from host cell membranes often requires the ESCRT
pathway, which can be engaged through the action of peptide motifs, termed late (L-) domains, in viral proteins. Viral PTAP
and YPDL-like L-domains bind directly to the ESCRT-I and ALIX components of the ESCRT pathway, while PPxY motifs bind
Nedd4-like, HECT-domain containing, ubiquitin ligases (e.g. WWP1). It has been unclear precisely how ubiquitin ligase
recruitment ultimately leads to particle release. Here, using a lysine-free viral Gag protein derived from the prototypic foamy
virus (PFV), where attachment of ubiquitin to Gag can be controlled, we show that several different HECT domains can
replace the WWP1 HECT domain in chimeric ubiquitin ligases and drive budding. Moreover, artificial recruitment of isolated
HECT domains to Gag is sufficient to stimulate budding. Conversely, the HECT domain becomes dispensable if the other
domains of WWP1 are directly fused to an ESCRT-1 protein. In each case where budding is driven by a HECT domain, its
catalytic activity is essential, but Gag ubiquitination is dispensable, suggesting that ubiquitin ligation to trans-acting
proteins drives budding. Paradoxically, however, we also demonstrate that direct fusion of a ubiquitin moiety to the C-
terminus of PFV Gag can also promote budding, suggesting that ubiquitination of Gag can substitute for ubiquitination of
trans-acting proteins. Depletion of Tsg101 and ALIX inhibits budding that is dependent on ubiquitin that is fused to Gag, or
ligated to trans-acting proteins through the action of a PPxY motif. These studies underscore the flexibility in the ways that
the ESCRT pathway can be engaged, and suggest a model in which the identity of the protein to which ubiquitin is attached
is not critical for subsequent recruitment of ubiquitin-binding components of the ESCRT pathway and viral budding to
proceed.
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Introduction
The membrane scission event that separates the lipid membrane
of nascent enveloped virions from host cell membranes is, in many
cases, an orchestrated event requiring the participation of the class
E vacuolar protein sorting (VPS), or endosomal sorting complex
required for transport (ESCRT) pathway. Ordinarily, the ESCRT
pathway induces topologically equivalent cellular membrane
scission events including the biogenesis of multivesicular bodies
(MVBs) [1,2] and the membrane abscission event at the conclusion
of cell division [3,4]. Components of the pathway can be recruited,
either directly or indirectly, through the action of short peptide
motifs called late (L-) domains in viral structural proteins [5,6].
Three classes of viral L-domains and cognate cofactors have been
defined thus far: PT/SAP motifs bind Tsg101 [7,8,9,10], LxxLF
or YPXL motifs bind ALIX [11,12,13], and PPxY domains bind
Nedd4-like HECT ubiquitin ligases [14,15,16,17,18]. Disruption
of late domain function results in the failure of membrane scission
and the accumulation of assembled virions that remain tethered to
the surface of the host cell by a continuous membrane.
The ESCRT machinery is composed of ,25 proteins, many of
which participate in the formation of several multiprotein complexes,
known as ESCRT-0, -I, -II, -III [19,20,21]. ESCRT-III components
are thought to drive the membrane scission event [22,23,24,25] and
appear to be generally required for L-domain-dependent viral
budding [7,11,12,13,26]. In contrast, other components of the
ESCRT-pathway appear to be required in an L-domain specific way.
For example, PTAP-dependent budding is especially sensitive to
ESCRT-I perturbation, whileYPXL-dependent budding is especially
sensitive to ALIX depletion. Since ALIX interacts directly with
ESCRT-III via its Bro1 domain [11,12,13,27,28] and ESCRT-I
indirectly interacts with ESCRT-III via ALIX and/or ESCRT-II,
[11,12,13] these observations suggest that YPXL and PTAP motifs
access the same core scission machinery via alternative routes.
In contrast, it has remained somewhat unclear how PPxY motifs
access the scission machinery. Overexpression of certain HECT
ubiquitin ligases that bind directly to PPxY or other motifs can
markedly stimulate budding, and the catalytic activity of the HECT
domain is essential for this activity [17,29,30,31]. Indeed,
overexpression of catalytically inactive or truncation mutants of
the HECT ligase WWP1 inhibits PPxY-dependent budding
[17,29]. Some components of the ESCRT pathway are also
required for PPxY-induced budding [7,31,32]. However, the
precise means by which HECT ligase recruitment subsequently
results in the engagement of the ESCRT machinery is not
completely defined. One model invokes direct ubiquitination of
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several components of the ESCRT pathway are thought to
recognize ubiquitinated cargo through various low affinity ubiqui-
tin-binding domains [7,33,34,35,36,37] and that monoubiquitina-
tion of cellular cargos can serve as a signal for endosomal trafficking
and delivery to the lysosome [21,38,39]. Indeed, several observa-
tions are consistent with the notion that ubiquitination of retroviral
Gag promotes virus particle release. For example, studies have
noted an enrichment of free ubiquitin in retrovirus particles, and
ubiquitinated Gag species have also been detected therein
[14,40,41,42,43]. Additionally, late budding defects have been
observed in cells treated with proteasome inhibitors, perhaps due to
the depletion of free ubiquitin [14,44,45]. Mutation of multiple
ubiquitin acceptor lysine residues in Gag has been shown to inhibit
particle production by retroviruses [46,47]. Finally, direct fusion of
ubiquitin to the C-terminus of Gag proteins has been shown to
alleviate inhibition of particle release imposed by proteasome
inhibitors, or to obviate the requirement for an L-domain in particle
release [44,48].
Other observations suggest that PPxY and ubiquitin ligase-
dependent budding may involve mechanisms other than direct Gag
ubiquitination. In particular, overexpression of wild-type WWP1
stimulates PPxY-dependent particle production by a lysine-freeGag
protein [29] in the absence of detectable Gag ubiquitination. This
finding suggests the possibility that HECT ligases may promote
budding by catalyzing the ubiquitination of specific trans-acting
host factors, rather than Gag. Additionally, a HECT-truncated
WWP1 protein, lacking the entire HECT domain, inhibits murine
leukemia virus (MLV) budding more potently than the full length
WWP1 protein with a disrupted active site [17], suggesting that
HECT domains may possess activities other than ubiquitin
conjugation that are important for their function in viral budding.
Moreover, HECT domains localize to aberrant endosomal (so
called class E) compartments induced by overexpression of
catalytically inactive ATPase VPS4 [17], which is required for the
disassembly of ESCRT complexes after each round of budding
[49,50]. Since many VPS factors are trapped on VPS4-induced
compartments, HECT domains may be recruited to these
compartments by interaction with VPS proteins, either directly or
through unidentified bridging factors. It has also been reported that
HECT ubiquitin ligases can bind to, and/or catalyze the ligation of
ubiquitin to, certain class E VPS factors [31,32,51]. Thus, the
ubiquitin ligases might act as recruitment factors rather than, or in
addition to, conjugating ubiquitin to key target proteins.
In this study we investigated the role of PPxY motifs, HECT
ubiquitin ligase domains and ubiquitin in viral budding, using a
lysine-free viral protein from the prototypic foamy virus (PFV), in
which the attachment of ubiquitin to Gag can be rather precisely
controlled. We show that the catalytic activity of a variety of HECT
domains, targeted to a PPxY motif in assembling particles via a
common C2/WW domain fragment of WWP1, is essential for their
ability to promote PPxY-dependent VLP release. In each case,
however, Gag ubiquitination is dispensable for their activity. Rather,
the ability of the chimeric ubiquitin ligases to promote budding
correlated broadly, albeit imperfectly, with their ability to catalyze
autoubiquitination, Moreover, we show that artificial recruitment of
an isolated HECT domain can also stimulate budding, while a
HECT domain becomes dispensable for PPxY motif dependent
budding if the C2/WW domains of WWP1 are directly linked to the
C-terminal domain of Tsg101, an ESCRT-I subunit. Finally, we
demonstrate that direct fusion of a single ubiquitin moiety to the C-
terminus of PFV Gag is also capable of promoting budding, in a
manner that recapitulates the ESCRT protein requirement for
budding induced by PPxY-dependent ubiquitin ligase recruitment in
the absence of ubiquitin acceptors in Gag. These results support a
model in which PPxY motif-induced HECT ubiquitin ligase
recruitment leads to the deposition of ubiquitin at or near the site
of viral budding. However, the identity of the protein to which
ubiquitin is attached, be it Gag or a bystander protein, perhaps
including the HECT ubiquitin ligase itself, does not appear to be
critical in order for subsequent recruitment of ubiquitin-binding class
E VPS proteins and viral budding to proceed.
Results
Chimeric ubiquitin ligases encoding a panel of HECT
domains stimulate PPxY-dependent budding with
variable efficiency
To ascertain what properties of HECT domains are important
for stimulation of virus particle release, we compared the properties
of a panel of HECT domains. Nine members of the Nedd4-like
HECT ubiquitin ligase family have been described in humans and
these have the same domain organization as a single prototype
member of this family in yeast, namely Rsp5 (reviewed in [52]).
Specifically, an N-terminal C2 domain directs the protein to
membranes, a central cluster of ‘WW’’ domains binds ligands, such
as PPxY motifs, and a C-terminal HECT domain harbors the E3
ubiquitin ligase activity. Some of the intact ubiquitin ligases have
been shown to vary in their ability to promote PPxY-dependent
MLVvirion release,dueat leastinpart todifferences inthe affinities
of their WW domains for the MLV L-domain [17], but whether the
various the C-terminal HECT domains are equivalently able to
induce particle release has not been investigated. We reasoned that
variation in the ability of HECT domains to stimulate virus
budding, correlated with a given property of the HECT domains,
might suggest properties that are important for inducing virion
release. Since WWP1 has been previously shown to be efficiently
recruited by a number of PPxY-type L-domains, including that of
MLV [17], we constructed a panel of chimeric ubiquitin ligases,
consisting of membrane targeting and PPxY motif-binding domains
(C2 and WW domains) of human WWP1, coupled to various
catalytic HECT domains derived from human WWP2, Nedd4,
Nedd4L, Itch, Smurf1, Bul2 or yeast Rsp5 HECT ligases (Fig. 1A).
Author Summary
The release of an enveloped virus particle from an infected
cell requires the separation of the viral and cell mem-
branes. Many enveloped viruses accomplish this by
parasitizing a set of cellular proteins, termed the ESCRT
pathway, that normally separates cellular membranes from
each other. In some cases, viral structural proteins encode
peptides motifs that bind directly to, and thereby recruit,
the ESCRT machinery. Alternatively, viruses can recruit
enzymes, termed ubiquitin ligases, that bind to other
proteins, and catalyze the addition of ubiquitin to them. It
has, heretofore, been somewhat unclear precisely how the
recruitment of ubiquitin ligases leads to the engagement
of the ESCRT machinery. We show that the simple
recruitment of a fragment of a ubiquitin ligase that is
responsible for the addition of ubiquitin to other proteins
is sufficient to drive virus particle release, even when it is
not possible to attach ubiquitin to viral proteins. Paradox-
ically, we also found that simple attachment of ubiquitin to
the same viral protein can also drive particle release. These
results show that there is flexibility in the ways in which
the ESCRT machinery can be recruited and how ubiquitin
can be co-opted to enable this.
Role of Ubiquitin Ligases in Viral Budding
PLoS Pathogens | www.plospathogens.org 2 October 2010 | Volume 6 | Issue 10 | e1001153Figure 1. Constructs used in this study. (A) Schematic representation of YFP-fused chimeric ubiquitin ligases containing the membrane targeting
(C2) and late domain binding (WW) domains of WWP1 and the indicated catalytic HECT domains. Wild type and catalytically inactive mutant versions
of each HECT ligase were constructed. (B) Schematic representation of the PFV Gag-derived proteins used in this study, containing a single K396R
mutation, an Lck-derived membrane targeting peptide appended to the N-terminus, and the indicated late domains.
doi:10.1371/journal.ppat.1001153.g001
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support viral budding, we co-expressed each of them with a
plasmid expressing a modified PFV Gag protein. Importantly,
PFV Gag offers the advantage that it is naturally almost devoid of
lysine resides. While PFV Gag normally requires a cognate Env
protein for particle release, we have previously shown that
appending a myristoylated, palmitoylated peptide from Lck at its
N-terminus can overcomes this requirement by directing PFV Gag
to the plasma membrane and thereby allowing the generation of
extracellular particles in the absence of any other viral protein
[29]. Throughout this study we used this N-terminally modified
Gag protein, termed Lck-Gag, bearing a K396R mutation that
renders the PFV Gag completely lysine-free. Examples of
engineered variants of this Gag protein are illustrated in Fig. 1B,
and include those that is otherwise unmodified and encode the
natural PSAP late domain (Lck-Gag(PSAP)), a PSAP mutant that
contains no known L-domain (Lck-Gag(L-)) or another variant
that has a PPxY late domain derived from MLV Gag appended to
its C-terminus (Lck-Gag-PY, Fig. 1B). In addition, we used an Lck-
Gag-PY derivative containing three lysine residues adjacent to a
PPxY late domain (Lck-Gag-PY-3K) to assess HECT ligase-
induced Gag ubiquitination ([29], illustrated in Fig. 1B).
Overexpression of ubiquitin ligases encoding a variety of
HECT domains (WWP1 itself, WWP1/Nedd4, WWP1/
Nedd4L, WWP1/Itch, WWP1/Smurf1, or WWP1/Bul2) stim-
ulated PPxY-dependent budding of lysine-free Lck-Gag-PY
(Fig. 2A,B). Conversely, WWP1/WWP2 and WWP1/Rsp5 did
not stimulate budding or had marginal activity. The strongest
stimulation was observed using chimeric ligases containing the
Nedd4L and Itch HECT domains. Importantly, overexpression
of chimeric ligases in which the catalytic cysteine was mutated to
serine, failed to stimulate PPxY-dependent particle release
(Fig. 2A), indicating that the catalytic activity of each HECT
domains was required, even when the viral structural proteins
lack ubiquitin acceptors.
Stimulation of Lck-Gag budding and HECT ubiquitin
ligase autoubiquitination
To assess the relative catalytic activities of the chimeric HECT
ligases, and assess whether this correlated with their differential
ability to promote budding, we compared their abilities to carry
out autoubiquitination and to ubiquitinate a Gag substrate
encoding three lysine residues in close proximity to a PPxY late
domain (Lck-Gag-PY-3K, see Fig. 1B). To accomplish this, we
immunoprecipitated either Gag or HECT ubiquitin ligases from
293T cell lysates, prepared 36 hours after co-transfection with
plasmids expressing Lck-Gag-PY-3K, HA-tagged ubiquitin, and
each of the YFP-fused chimeric HECT ligases. Cell lysates were
prepared using denaturing, detergent-rich buffer (containing 0.5%
SDS) to ensure dissolution of protein complexes, and ubiquitinated
species were detected by immunoprecipitation with either aPFV
Gag or aGFP antibodies followed by immunoblot analysis of the
precipitates with an aHA antibody (Fig. 3).
Each of the chimeric HECT ubiquitin ligases was able to
reasonably efficiently catalyze the addition of 1 to 3 ubiquitin
moieties to the Lck-Gag-PY-3K substrate (Fig. 3A, upper panels).
There was some variation in the ability of the HECT domains to
catalyze the ligation of ubiquitin to Lck-Gag-PY-3K, with
WWP1/Rsp5 and WWP1/Bul2 catalyzing the highest and
WWP1/Nedd4 the lowest levels of ubiquitin ligation to Lck-
Gag-PY-3K (Fig. 3A). However, there was no correlation between
the extent to which each HECT domain stimulated Lck-Gag-PY-
3K ubiquitination (Fig. 3A) and the degree to which it stimulated
the release of VLPs assembled using Lck-Gag-PY or Lck-Gag-PY-
3K (Fig. 2A and data not shown). For example, WWP1/Bul2 and
WWP1/Nedd4, which induced the highest and lowest levels of
Gag ubiquitination, respectively (Fig. 3A), stimulated budding to a
similar extent (about 6-fold, Fig. 2A). Moreover, WWP1/Rsp5,
which efficiently catalyzed Gag ubiquitination (Fig. 3A), enhanced
particle release only marginally (Fig. 2A), much less efficiently than
the WWP1/Nedd4L that induced comparatively modest levels of
Gag ubiquitination (Fig. 3A).
We observed a better, albeit imperfect, correlation between the
ability of the chimeric HECT ligases to catalyze autoubiquitina-
tion and to stimulate VLP production (Fig. 3B, Fig. 2B). Chimeric
ligases that strongly promoted Lck-Gag-PY VLP release (e.g.
WWP1/Itch and WWP1/Nedd4L) were more heavily autoubi-
quitinated, while those that failed or only marginally promoted
VLP release (WWP1/WWP2 and WWP1/Rsp5, Fig. 2) exhibited
the lowest levels of autoubiquitination (Fig. 3B). The correlation
was imperfect, however, since WWP1/Nedd4, which moderately
enhanced particle release (Fig. 2), was consistently highly auto-
ubiquitinated (Fig. 3B). Notably, there was no correlation between
the ability of the HECT ubiquitin ligases to catalyze autoubiqui-
tination, and their ability to catalyze ubiquitin ligation to Lck-Gag-
PY-3K (Fig. 3A, B). Overall, these data confirm our previous
finding that direct Gag ubiquitination is dispensable for HECT
ligase-dependent budding [29] and further indicates that intrinsic
catalytic activity of the HECT ubiquitin ligases is critical for their
ability to stimulate budding.
Reciprocal exchange of HECT ubiquitin ligase and Tsg101
domains results in functional hybrid L-domain cofactors
that can promote viral budding
We next asked whether the need to recruit a HECT domain in
the context of PPxY/WWP1 interaction was necessary for
particle release, or whether the HECT domain could be bypassed
by direct recruitment of putative downstream effectors. Addi-
tionally, we asked whether recruitment of a HECT domain in the
absence of the other domains (C2 and WW) found in the Nedd4-
like family of proteins was sufficient to stimulate particle budding.
To accomplish this, we constructed hybrid L-domain cofactors in
which the essential domains were split and linked to putatively
complementing domains in another L-domain cofactor (Fig. 4A).
Specifically, Tsg101 is a core component of ESCRT-I and
contains two domains that are functionally important with respect
to viral budding. The N-terminal ubiquitin E2 variant (UEV)
domain interacts directly with P(T/S)AP peptide motifs and
ubiquitin [7], while the C-terminal portion of the protein is a key
structural component of ESCRT-I, interacting with other
components, e.g. VPS28 and VPS37 [53,54,55] and is essential
to support Tsg101 dependent budding. We constructed an
artificial putative chimeric L-domain cofactor in which the C2/
WW domains of WWP1 were linked to the C-terminal portion of
Tsg101 (Tsg-C) that constitutes the core structural component of
ESCRT-I (residues 157–390, Fig. 4A). Notably, overexpression of
this chimeric protein, termed WWP1-Tsg-C, stimulated Lck-
Gag-PY particle release in a dose-dependent manner but had no
effect on particle production by the L-domain-deficient Lck-
Gag(L-) protein (Fig. 4B, left and middle panels). This chimeric
protein, therefore, appeared capable of recruiting a functional
ESCRT-I complex to PPxY L-domains and thereby stimulating
particle production. Conversely, WWP1-Tsg-C overexpression
inhibited Lck-Gag(PSAP) budding in a dose-dependent manner
(Fig. 4B, right panel). We surmise that since this chimeric protein
lacks the domains required for interaction with PT/SAP motifs, it
acts as an inhibitor of PSAP-dependent budding by sequestering
endogenous components (e.g. VPS28 and VPS37) into retargeted
Role of Ubiquitin Ligases in Viral Budding
PLoS Pathogens | www.plospathogens.org 4 October 2010 | Volume 6 | Issue 10 | e1001153Figure 2. Stimulation of PPxY-dependent VLP production by chimeric HECT ubiquitin ligases. (A) Quantitative Western blot (LICOR)
analysis of VLP release from 293T cells co-expressing Lck-Gag-PY and either YFP alone (None) or the indicated YFP-fused WWP1 C2/WW domains
linked to the indicated HECT domains. Note that the unfused YFP is not visible in the ‘‘None’’ lane because it migrates to a different position on the
blot. (B) Quantitation of Lck-Gag-PY protein in particles by quantitative Western blot analysis (LICOR). Values plotted are the levels of VLP associated
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SAP, L-domains. Thus, these experiments demonstrate that the
requirement for a HECT domain (and, by inference, the
requirement for ubiquitin ligation) in PPxY/ubiquitin ligase
dependent viral budding can be bypassed, if an alternative link to
the ESCRT machinery is provided.
Figure 3. Chimeric HECT ligases catalyze varying levels of Lck-Gag-PY-3K ubiquitination and autoubiquitination. Quantitative
Western blot analysis of lysine-containing Lck-Gag-PY-3K proteins (A) and chimeric HECT ligase proteins (B), immunoprecipitated from 293T cells
following cotransfection with plasmids expressing Lck-Gag-PY-3K, HA-ubiquitin, and the indicated chimeric YFP-WWP1/HECT ubiquitin ligases. The
aPFV Gag immunoprecipitates were probed with an aHA monoclonal antibody (A, top panel) or aPFV serum (A, middle panel). The aGFP
immunoprecipitates were probed with aHA (B, top panel) and aGFP (B, middle panel) monoclonal antibodies. Alternatively, unfractionated cell
lysates were probed with aPFV serum or aGFP antibody (A and B, bottom panels). Lanes marked ‘‘none’’ contain immunoprecipitates or lysates from
cells transfected with unfused YFP in place of a YFP-fused ubiquitin ligase. Note that the unfused YFP is not visible in these lanes because is migrates
to a different position on the blot. Charts below each plot show quantitation (mean+SD of two experiments) of the total signals in each lane of the
blots in the upper panels that were probed for HA-ubiquitin. The levels of Gag ubiquitination and autoubiquitination are presented relative to that
observed in the presence of intact WWP1, which was assigned a value of 1.
doi:10.1371/journal.ppat.1001153.g003
Lck-Gag-PY protein generated in the presence of the indicated YFP-fused chimeric ubiquitin ligase, relative to that generated in the presence of YFP
only (None). Data represent the mean and standard deviation of four independent experiments.
doi:10.1371/journal.ppat.1001153.g002
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PLoS Pathogens | www.plospathogens.org 7 October 2010 | Volume 6 | Issue 10 | e1001153In a reciprocal experiment, we asked whether the PPxY motif
and the C2/WW domains of WWP1 could be functionally
replaced in the context of HECT domain/ubiquitin dependent
budding. In other words, we determined whether recruitment of a
HECT domain is sufficient to stimulate particle release, in the
absence of the other protein domains (C2 and WW) to which it
would ordinarily be linked. Specifically, we attempted to redirect
P(T/S)AP-dependent particle production through a HECT
domain-dependent pathway, by constructing chimeric proteins,
termed Tsg-WWP1, Tsg-Itch and Tsg-Nedd4L, that contained the
N-terminal UEV domain (residues 1–157) of Tsg101 linked to one
of the three respective HECT domains (Fig. 4A). To test the
function of these artificial putative L-domain cofactors, we also
constructed an attenuated ‘‘leaky’’ mutant of the PT/SAP motif in
the Lck-Gag(PSAP) protein, namely Lck-Gag(ASAP), by mutating
the first proline residue of the PSAP motif to alanine. In the
context of the HIV-1 PTAP motif, such a mutation reduces the
affinity for, but does not eliminate binding to the Tsg101 UEV
domain [7]. Correspondingly, the budding of Lck-Gag(ASAP),
was attenuated as compared to Lck-Gag(PSAP), but the ASAP
motif clearly retained some weak residual ability to stimulate
budding (Fig. 4C, leftmost three lanes), suggesting that it retains
some residual ability to recruit the Tsg101 UEV domain.
Overexpression of Tsg-WWP1, Tsg-Itch or Tsg-Nedd4L,
respectively) resulted in clear stimulation of Lck-Gag(ASAP)
budding (Fig. 4C). Tsg101-Itch was the most potent of the three
Tsg101-HECT proteins tested by this approach, and its
overexpression resulted in a particle yield that matched or even
exceeded that observed in the presence of the intact PSAP motif
(Fig. 4C). In contrast, expression of catalytically inactive versions
of Tsg-WWP1, Tsg-Itch or Tsg-Nedd4L inhibited rather than
enhanced Lck-Gag(ASAP) particle production (Fig. 4C). Because
the Tsg101 UEV domain contains ubiquitin-binding activity that
might complicate the interpretation of these results, we repeated
these experiments using a mutant Tsg101 UEV domain (N45A)
that is defective for ubiquitin binding, linked to a WWP1 HECT
domain. The mutant Tsg(N45A)-WWP1 fusion stimulated bud-
ding at least as efficiently as did the unmanipulated Tsg-WWP1
protein (Fig. 4D).
Overall, the experiments in Fig. 4 demonstrate that the domains
of the PTAP and PPxY binding cofactors can be functionally split
into modular, interchangeable domains that are (i) necessary for
binding to the L-domain and (ii) interface with downstream
effectors that are critical for budding. Most notably, these findings
suggest that simple recruitment of a HECT domain to sites of
particle budding, irrespective of its mode of recruitment, and in
the absence of ubiquitin acceptors on the viral protein, is sufficient
to stimulate particle release and that other HECT ubiquitin ligase
domains are dispensable for budding.
Direct fusion of ubiquitin to Lck-Gag promotes particle
release
The aforementioned experiments demonstrated that the
requirement for a catalytically active HECT domain could be
obviated by direct recruitment of ESCRT-I to a viral protein (Lck-
Gag-PY) whose budding would normally be dependent on such
recruitment. We next asked whether the requirement for HECT
domain recruitment could similarly be obviated, in the context of a
nearly identical viral protein, by simply depositing ubiquitin at the
site of particle assembly, in the absence of ubiquitin ligase
recruitment. To mimic the deposition of ubiquitin at sites of virion
assembly, in the absence of ubiquitin ligase recruitment, we
expressed an Lck-Gag protein, lacking L-domains, with a single
ubiquitin appended at its C-terminus (Lck-Gag-Ub, Fig. 5A).
Ubiquitin is normally conjugated to proteins by an isopeptide
bond between the C-terminal glycine residue of ubiquitin and the
e-amino group of a lysine residue within the substrate protein.
Therefore, to avoid aberrant conjugation of our Gag-ubiquitin
chimeras to other proteins we deleted two glycine residues from
the C-terminus of ubiquitin (Fig. 5A).
Cells expressing ubiquitin-fused, but L-domain-deficient Gag
(Lck-Gag-Ub) generated extracellular particles while those ex-
pressing the unfused, L-domain deficient counterpart Lck-Gag(L-)
protein did not (Fig. 5B). Directly fused ubiquitin-dependent
particle release was strongly inhibited, in a dose dependent
manner, by expression of a catalytically inactive version of the
ATPase VPS4 (Fig. 5C), indicating that the ESCRT pathway was
required for Lck-Gag-Ub particle release. Thus, in the context of
Lck-Gag, direct ubiquitin fusion appeared capable of substituting
for a PSAP or PPxY containing L-domain. These results are
similar to findings made by Joshi et al. who showed that direct
fusion of ubiquitin to EIAV Gag can functionally substitute for the
ALIX-binding YPDL L-domain encoded therein [48]. Similarly,
we also found that ubiquitin-dependent budding was dependent
on the ubiquitin hydrophobic patch residues (L8 and I44) and
additionally, marginally dependent on residues (Q62 and E64) that
have been implicated in ubiquitin-Tsg101 UEV domain interac-
tion (Fig. 5D). However, lysine residues (K48 and K63) that are
often important for the conjugation of further ubiquitin molecules
could be mutated without affecting fused ubiquitin-dependent
particle release (Fig. 5D).
Ubiquitin and PSAP motifs synergize to stimulate Lck-
Gag VLP release
Next we analyzed the effect of combining L-domains and
ubiquitin on VLP release. To accomplish this, Lck-Gag proteins
containing various combinations of the L-domains and C-
terminally fused ubiquitin (Fig. 6A) were expressed. Quantitative
analyses revealed that directly fused ubiquitin-dependent (Lck-
Gag-Ub) particle release was at least as efficient as that driven by
PSAP (Lck-Gag(PSAP)) or PPxY (Lck-Gag-PY) L-domains
(Fig. 6B). Moreover, and in contrast to the previous report with
EIAV Gag [48], we found that the combined presence of fused
ubiquitin and a PSAP L-domain (in Lck-Gag(PSAP)-Ub) resulted
in strongly synergistic effects on particle release (Fig. 6B).
Specifically, Lck-Gag(PSAP)-Ub generated ,20-fold and ,6-fold
more particles than Lck-Gag(PSAP) and Lck-Gag-Ub, respectively
(Fig. 6B). No such synergy was observed when a PPxY L-domain
Figure 4. Exchange of functional domains in L-domain cofactors. (A) Schematic representation of chimeric proteins designed to recruit
ESCRT-I to PPxY motif (WWP1-Tsg-C), and isolated catalytic domain of a HECT ubiquitin ligase to a PTAP motif (Tsg-WWP1, Tsg-Itch and Tsg-Nedd4L).
(B) Stimulation of PPxY-dependent budding in the absence of a HECT domain by direct recruitment of ESCRT-I. Specifically, VLP production from 293T
cells expressing Lck-Gag-PY, Lck-Gag(L-) or Lck-Gag(PSAP) and increasing amounts of YFP-fused WWP1-Tsg-C (the amount of cotransfected WWP1-
Tsg-C expression plasmid (in mg) is indicated) was assessed by western blotting. (C,D) VLP production from 293T cells expressing Lck-Gag containing
either a wild-type (Lck-Gag(PSAP)), inactive Lck-Gag(L-), or attenuated Lck-Gag(ASAP) late domain and the indicated WT or catalytically inactive
mutant (C/S) chimeric Tsg-WWP1, Tsg-Itch and Tsg-Nedd4L proteins was assessed by western blotting. The three leftmost lanes in (C) and the single
leftmost lane in (D) contain lysates from cells transfected with unfused YFP as a control in place of a YFP-fused Tsg-HECT protein. Note that the
unfused YFP is not visible in these lanes because it migrates to a different position on the blot.
doi:10.1371/journal.ppat.1001153.g004
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Lck-Gag-Ub and the Lck-Gag-PY-Ub generated extracellular
particles with approximately the same efficiency (Fig. 6B). Less
dramatic, but nonetheless synergistic enhancement of particle
release was evident when PPxY and PSAP motifs were both
present (in the absence of ubiquitin fusion, Fig. 6B). In this case,
the presence of the PPxY motif (in Lck-Gag(PSAP)-PY) enhanced
particle release approximately ,5-fold as compared to the
situation where the PSAP motif was the only L-domain (in Lck-
Gag(PSAP), Fig. 6B). Overall these results are consistent with the
notion that ubiquitin behaves essentially like an L-domain, and
further suggests that it functions synergistically with a PT/SAP
motif, and redundantly with a PPxY motif.
We next attempted to mimic a situation that is somewhat typical
of retroviruses, where only a fraction of Gag expressed in cells
carries ubiquitin. This was done by co-expressing ubiquitin-fused
and unfused Lck-Gag proteins in varying proportions. When this
was done in the context of a Lck-Gag proteins lacking a PSAP
Figure 5. Direct fusion of ubiquitin to Lck-Gag stimulates L-domain-dependent and -independent budding. (A) Schematic
representation of the Lck-Gag-Ub protein with a single ubiquitin moiety fused at the carboxyl terminus. Two glycine residues were removed from the
C-terminus of ubiquitin to prevent its conjugation to other proteins. (B) VLP production from 293T cells expressing the Lck-Gag-Ub protein, or a
control Lck-Gag(L-) protein was assessed by western blotting. (C) VLP production from 293T cells expressing Lck-Gag-Ub and increasing amounts of
GFP-Vps4 (E228Q). (D) VLP release from 293T cells expressing Lck-Gag-Ub containing the indicated mutations in C-terminally fused ubiquitin.
doi:10.1371/journal.ppat.1001153.g005
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production was most efficient when a large fraction of the total
Lck-Gag protein carried ubiquitin, and no stimulation of particle
production was detectable when less than 25% of the Gag protein
carried fused ubiquitin (Fig. 6C, left panel). When similar
experiments were done in the presence of a PSAP late domain,
by co-expressing Lck-Gag(PSAP) and Lck-Gag(PSAP)-Ub, stimu-
lation of particle release was observed when smaller fractions of
Gag, as little as a few percent, carried ubiquitin (Fig. 6C, right
panel). Nonetheless, larger fractions of ubiquitin fused Gag had
larger stimulating effects on particle release. Thus, these
experiments suggest that the greater the number of ubiquitin
molecules that are present at sites of particle assembly, the more
efficient is particle release; however, relatively modest amounts of
ubiquitin can significantly enhance particle budding in the
presence of a PSAP motif.
PPxY L-domain-dependent and directly fused ubiquitin-
dependent particle release are similarly dependent on
particular ubiquitin binding class E VPS factors
Several class E vacuolar protein-sorting factors have been
reported to possess ubiquitin binding activity (Table 1). Although
the affinity of such domains for monoubiquitin is generally quite
weak (Kd.100mM), several class E factors form multiprotein
complexes with several ubiquitin-binding surfaces, which could
provide sufficient avidity for their retention at sites of virion
assembly. Under such a scenario, efficient recruitment of ESCRT
complexes might require deposition of relatively large numbers of
ubiquitin molecules in the vicinity of the assembling particle, a
notion that is consistent with the finding that a large fraction of
Gag must carry ubiquitin to compensate for the absence of a late
domain (Fig. 6C).
To determine which of the mammalian ESCRT complexes and
associated proteins might be most important for ubiquitin
dependent budding, we performed a directed yeast two-hybrid
screen in which ubiquitin binding to a range of human class E
VPS factors and associated proteins was surveyed. These included
components of ESCRT-0 (Hrs, HBP/STAM), ESCRT-I (Tsg101,
VPS28, VPS37A,B,C, Mvb12), ESCRT-II (Eap20, Eap30, Eap45)
ESCRT-III (CHMP1A, 1B, 2A, 2B, 3, 4A, 4B, 4C, 5, 6), as well as
several ESCRT-associated proteins or proteins that are known to
bind to components of the class E VPS pathway (ALIX, LIP5,
VPS4, UBPY,CMS, CIN85). Most of these proteins, including
known ubiquitin binding factors (Table 1), gave either weak or
non-specific signals. Since we were testing ubiquitin binding by
each protein individually and outside of its natural context and in
the absence of ESCRT complex partners, it was perhaps to be
expected that this assay would fail to detect ubiquitin interactions
in at least some instances. Nonetheless, HBP/STAM, ALIX, and
UBPY binding gave robust signals in WT ubiquitin binding assays,
and binding was abolished when the ubiquitin hydrophobic patch
was mutated (I44A), (Fig. 7A).
We next determined the effect of siRNA mediated disruption of
known ubiquitin-binding complexes, as well the additional
ESCRT-associated factors that were positive in our yeast 2-hybrid
survey (ALIX and UBPY), on PPxY-dependent and fused
ubiquitin-dependent Lck-Gag budding. The core components of
the known ubiquitin binding ESCRT complexes (ESCRT-0,
ESCRT-I and ESCRT-II) were targeted using pools of four
siRNAs directed to Hrs, Tsg101 and Eap45, respectively. The
potency of the siRNA pools was estimated by cotransfecting them
with plasmids expressing YFP-tagged target proteins, followed by
quantitative western blotting. By these criteria the Tsg101, Eap45,
ALIX and UBPY siRNAs appeared effective (Fig. 7B). However,
knockdown of Hrs was inefficient, so its effect on budding could
not be reliably assessed. Because antibodies to Tsg101 and ALIX
were available, the level of endogenous proteins could also be
monitored in these siRNA experiments. Quantitative western
blotting analyses (examples are shown in Fig. 7C) indicated that
Tsg101 and ALIX proteins were reduced to 3869% and 1664%
of endogenous levels, respectively. Notably, control experiments
showed that Lck-Gag(PSAP) particle release was specifically
Table 1. Class E VPS factors and associated proteins encoding ubiquitin binding domains.
Protein Domain type Kd Methods References
Tsg101 UEV ,500mM SPR, NMR, structure [7,34,59,60]
Hrs DUIM, VHS ,300mM, ,1.4mM IP, SPR, structure [34,35,36,61,62,63]
STAM UIM, VHS, ,430mM, ,220mM IP, NMR, Y2H [33,64,65,66], this study
Eap45 GLUE ,300mM IP, SPR, structure [37,67,68]
Eps15 UIM ,0.36mM IP, SPR [35,36]
ALIX Unknown IP, Y2H [48], this study
CIN85 SH3 IP [69]
SPR: surface plasmon resonance; NMR: nuclear magnetic resonance; IP: immunoprecipitation or bead based ‘pull-down’ assays; Y2H: yeast 2-hybrid.
doi:10.1371/journal.ppat.1001153.t001
Figure 6. Synergy between a PSAP motif and ubiquitin during viral budding and effect of Gag-ubiquitin levels on particle release.
(A) Schematic representation of some examples of the Lck-Gag proteins used in these experiments, encoding PSAP and/or PPxY L-domains and a
single ubiquitin moiety fused at the carboxyl-terminus. (B) VLP release from by 293T cells expressing Lck-Gag proteins containing the indicated L-
domains that were present alone or in combination with each other and/or directly fused ubiquitin (see panel A), measured by quantitative western
blotting. The chart to the right of the blot shows the yield of VLPs (mean+SD of 2 experiments) and values are presented relative to the VLP yield
obtained in the presence of both L-domains and ubiquitin (Lck-Gag(PSAP)-PY-Ub), which was assigned a value of 1. (C) VLP production from 293T
cells expressing Lck-Gag(L-) or Lck-Gag(PSAP) proteins, where the total amount of Gag protein expressed was constant, but varying proportions
carried a fused ubiquitin. Cells were transfected with equal total amounts of Lck-Gag(L-)+Lck-Gag-Ub (left panels) or Lck-Gag(PSAP)+Lck-Gag(PSAP)-
Ub expression plasmids, and the indicated fraction of the total transfected plasmid mixture expressed the ubiquitin fused form of the Gag protein.
VLPs were harvested both at 24h and 48h after transfection and subjected to western blot analysis with aPFV antiserum.
doi:10.1371/journal.ppat.1001153.g006
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hybrid analysis of the interaction between the indicated class E VPS factors and ubiquitin containing either an intact (Ub WT) or disrupted (Ub I44A)
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by EAP45, ALIX and UBPY depletion (Fig. 7C,D), while EIAV
Gag particle release was specifically inhibited (,3-fold) by ALIX
depletion, but not by depletion of the other ESCRT-associated
proteins (Fig. 7C,D).
Ubiquitin-dependent (Lck-Gag-Ub) budding was modestly
inhibited (,3-fold) by depletion of either Tsg101 or ALIX but
was barely affected by UBPY or Eap45 siRNAs (Fig. 7C,D),
suggesting that ubiquitin binding to ESCRT-I and ALIX
contributes to its ability to mediate particle release. This finding
mirrors a previous report using ubiquitin fused to EIAV Gag [48].
Additionally, however, we further found that Lck-Gag-PY
exhibited a similar pattern sensitivity to class E factor-targeting
siRNAs, in that it was modestly sensitive to Tsg101 and ALIX but
not Eap45 or UBPY siRNAs (Fig. 7C,D). Similarly, the budding of
an MLV Gag protein, that carries the same PPxY L-domain was
also modestly sensitive to depletion of Tsg101 and ALIX
Fig. 7C,D).
Because ESCRT-I and ALIX perturbation both affected
ubiquitin and PPxY-dependent budding, we sought to determine
whether their simultaneous depletion would exhibit a stronger
inhibitory effect. Unfortunately, cotransfection of the two pools of
siRNAs (or each pool together with normalizing control RNA
duplexes,) rendered each somewhat less effective, perhaps due to
dilution of the active siRNAs (Fig. 8A). Specifically, Tsg101
protein levels were reduced to 4262% and 5062% of endogenous
levels, while ALIX protein levels were reduced to 3063% and
2762% of endogenous levels, when the Tsg101 or ALIX targeted
siRNAs were cotransfected together or with normalizing control
siRNAs, respectively (Fig. 8A). Thus, under these conditions,
siRNAs targeting ALIX did not inhibit Lck-Gag-Ub or Lck-Gag-
PY particle release (Fig. 8A,B). Nevertheless, simultaneous (albeit
partial) depletion of Tsg101 and ALIX had a significantly stronger
inhibitory effect on Lck-Gag-Ub, Lck-Gag-PY and MLV Gag
budding (Fig. 8A, B) than did the more effective individual
depletion of either Tsg101 or ALIX alone (Fig. 7C, D), suggesting
that they both proteins contribute to optimal PPxY and ubiquitin-
dependent budding.
Discussion
The precise role of HECT ubiquitin ligases in promoting PPxY-
dependent virion release has, heretofore, been somewhat unclear.
Our previous studies suggest that their ubiquitin ligase activity is
critical for their ability to stimulate budding [17,29], but the
functionally relevant substrate for ubiquitination has been difficult
to define. Additionally, there is some evidence suggesting that
HECT ubiquitin ligases may also function as adaptors for bridging
factors that recruit ESCRT proteins to assembling virions
[17,32,51].
We compared the activities of HECT domains from various
Nedd4-like family HECT ubiquitin ligases by fusing them to the
C2 and WW domains of WWP1. While this strategy does not
illuminate which ubiquitin ligases are responsible for viral budding
in the natural context, it does allow an assessment of HECT
domain function in a uniform background. We found that HECT
domains varied significantly in their ability to stimulate PPxY-
dependent particle release in this context. This variability was
evident when there were no ubiquitin acceptors in the Gag protein
and correlated better with the ability of the HECT domains to
drive autoubiquitination than with their ability to ubiquitinate a
modified Gag substrate that contained lysines proximal to a PPxY
motif. The correlation between autoubiquitination and budding
was imperfect, however, and it is possible that variation among the
HECT domains in their ability to catalyze different lengths and
types of ubiquitin chains (e.g. K48 versus K63-linked chains), or
their ability to ubiquitinate other bystander proteins, could
influence their ability to stimulate viral budding. In this regard it
was notable that there was no correlation between the ability of the
HECT domains to undergo autoubiquitination versus their ability
to catalyze ubiquitin ligation to Lck-Gag-PY-3K. It was nonethe-
less true that the ability of the HECT domains to stimulate
budding was, in every case, absolutely dependent on their ability to
catalyze the ligation of ubiquitin to a substrate. This suggests that
the proposed role of HECT domains as adaptors that bind directly
to downstream factors is of secondary importance in stimulating
budding, or that this adaptor function requires catalytic activity.
This latter scenario could, conceivably, be operative as a result of
HECT autoubiquitination.
These studies underscore the remarkable flexibility in the ways
that the ESCRT pathway can be engaged to achieve viral budding
(Fig. 9) Using a single viral Gag protein as a model, particle
budding could be achieved by: (i) conventional direct recruitment
of the ESCRT pathway via PTAP binding to Tsg101, (ii) direct
recruitment of the ESCRT pathway via PPxY binding to a hybrid
cofactor consisting of the C2/WW domains of WWP-1 linked to
the C-terminal domain of Tsg101, (iii) recruitment of a HECT
ubiquitin ligase via a PPxY motif, (iv) recruitment of an isolated
HECT domain to a PTAP motif using a hybrid L-domain cofactor
consisting of the UEV domain of Tsg101 linked to a HECT
domain or (v) direct fusion of ubiquitin to Gag. These results
suggest that the cellular factors (in this case Tsg101, ubiquitin
ligases and ubiquitin) that are either directly recruited or deposited
at the site of viral particle budding behave as modular entities,
with domains that are necessary and sufficient for their own
recruitment, and distinct domains that are necessary and sufficient
for the subsequent recruitment of downstream effectors of particle
release (Fig. 9).
When HECT domains were used to promote budding, the
requirement for catalytic activity was absolute, irrespective of how
they were recruited to Gag and, importantly, in the absence of
ubiquitin acceptors on the viral Gag protein. This finding suggests
that ligation of ubiquitin to trans-acting factors, perhaps including
the HECT domain itself (i.e. autoubiquitination), rather than Gag
hydrophobic patch. b-galactosidase expression was measured (as optical density at 540nm (OD540)) in Y190 cells transformed with the indicated
Gal4-DNA binding domain-ubiquitin and VP16 activation domain (-HBP, -ALIX, and -UBPY) fusion constructs. Absence of a bar indicates background
levels of b-galactosidase expression. A single representative of two independent experiments is shown. (B) Validation of siRNAs targeting ubiquitin-
binding ESCRT-complexes or other class E VPS factors. Lysates of 293T cells transfected with GFP-Tsg101 or YFP-Hrs, -ALIX, -UBPY, or -Eap45
expression plasmids and siRNAs targeting either luciferase (2) or the specified class E VPS factors (+) were probed with an aGFP monoclonal
antibody. (C) L-domain-specific inhibition of Gag budding by class E factor depletion. Quantitative Western blot analysis of VLP production from 293T
cells transfected with plasmids expressing Lck-Gag(PSAP), EIAV Gag, Lck-Gag-Ub, Lck-Gag-PY or MLV Gag-HA and siRNAs directed against the
indicated class E VPS protein. Corresponding cell lysates were also probed with antibodies to PFV, EIAV, HA, Tsg101 and/or ALIX, as appropriate. (D)
Quantitation of VLP release following knockdown of the indicated class E VPS proteins. Values are plotted the mean+SD of two or three independent
experiments and represent the levels of particles released relative to those released from cells transfected with control luciferase siRNAs, which was
assigned a value of 1.
doi:10.1371/journal.ppat.1001153.g007
Role of Ubiquitin Ligases in Viral Budding
PLoS Pathogens | www.plospathogens.org 13 October 2010 | Volume 6 | Issue 10 | e1001153is important for viral budding. It is superficially paradoxical,
therefore, that ubiquitin could promote budding of the very same
Gag protein even when ubiquitin was not ligated to a trans-acting
factor, but rather was directly fused to Gag. These findings suggest
that the identity of the protein(s) to which ubiquitin is attached is
not of critical importance, and ubiquitination substrates can, in
principle, include Gag, the ubiquitin ligase itself, or other trans-
acting proteins. The mere presence of ubiquitin at the site of
particle assembly appears sufficient to engage the ESCRT
pathway and stimulate budding.
The intrinsic manipulability of L-domains, the proteins that
bind to them (specifically ESCRT-I and HECT ubiquitin ligases)
and the apparent lack of importance of the identity of
ubiquitination substrate suggests that each serve simply as
recruitment factors to engage the downstream machinery that
mediates membrane fission and particle release. Since ubiquitin
binds to the very same factors (ESCRT-I and ALIX) that are
bound by PT/SAP and YPXL type L-domains, and depends on
them to stimulate budding, then ubiquitin itself can be
conceptually viewed, in the context of viral budding, as a
Figure 8. Effect of simultaneous ESCRT-I and ALIX disruption on ubiquitin-dependent and PPxY-dependent particle release. (A)
Quantitative Western blot analysis of VLP production from 293T cells transfected with plasmids expressing Lck-Gag-Ub, Lck-Gag-PY or MLV Gag-HA
and siRNAs targeting Tsg101, ALIX or both. Corresponding cell lysates were also probed with antibodies to PFV, HA, Tsg101 and/or ALIX, as
appropriate, and as indicated. (B) Quantitation of VLP release following knockdown of Tsg101, ALIX or both. Values are plotted as the mean+SD of
two or three independent experiments and represent the levels of particles released relative to those released from cells transfected with control
luciferase siRNAs, which was assigned a value of 1.
doi:10.1371/journal.ppat.1001153.g008
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variety of natural and artificial mechanisms (i)–(v) that include ubiquitin ligation to trans-acting proteins, (perhaps including the ubiquitin ligase itself)
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In essence, this notion is a simple extension of the concept
originally demonstrated by Parent et al, who showed that
conventional L-domains function in a position independent,
transferable manner [56].
A finding that is consistent with the aforementioned arguments,
is that budding that was dependent either on a PPxY motif or a
ubiquitin fused directly to Gag exhibited similar dependence on
particular components of the ESCRT pathway. Notably, pertur-
bation of individual segments of the pathway (ESCRT-I and
ALIX) caused partial inhibition of ubiquitin-dependent Lck-Gag-
PY, Lck-Gag-Ub and MLV Gag particle release. Previous work
has shown that Mason-Pfizer monkey virus particle release, which
is dependent on a PPxY motif, is quite strongly inhibited by
depletion of Tsg101 [31] and that budding of a EIAV Gag-
ubiquitin fusion protein is modestly inhibited by Tsg101 or ALIX
depletion [48]. We found that simultaneous perturbation of
ESCRT-I and ALIX resulted a stronger suppression of Lck-Gag-
PY, Lck-Gag-Ub and MLV Gag particle release than did
depletion of either protein alone, suggesting that both ESCRT-I
and ALIX can contribute to optimal PPxY- and ubiquitin-
dependent budding (Fig. 9). Indeed, the class E VPS pathway
includes multiple ubiquitin-interacting factors, each of which
could, in principle, provide parallel mechanisms for engaging the
ESCRT machinery. While ESCRT-I and ALIX appeared to be
most important for PPxY- and ubiquitin-dependent budding, these
experiments do not exclude a contributory role for other ubiquitin
binding complexes in the ESCRT pathway. A similar notion was
recently demonstrated in yeast, where simultaneous disruption of
ubiquitin binding by ESCRT-I, -II and Bro1 (the yeast homologue
of ALIX) was necessary to block the sorting of ubiquitinated cargo
to the lysosome [57]. Thus, ubiquitin has several potential entry
points into the ESCRT pathway, and it appears that multiple
interactions must be simultaneously inhibited in order to
profoundly inhibit ubiquitin- or HECT ligase-dependent budding.
Since ubiquitin-binding class E VPS factors generally have a
low affinity for individual ubiquitin molecules (Table 1), the
efficiency with which they are recruited to, and retained at, sites of
particle assembly is likely related to the number of ubiquitin
molecules that are locally present. Indeed, in the context of direct
ubiquitin fusion to Lck-Gag, particle release efficiency increased as
the proportion of Gag molecules that carried a ubiquitin was
increased, and directly fused ubiquitin could effectively bypass the
need for a conventional L-domain only when a large fraction
(.50%) of the Gag molecules were fused to ubiquitin. This
approximates to ,1000 to 2500 ubiquitin molecules per
assembling virion.
Previous studies have shown that direct ubiquitin fusion to RSV
or EIAV Gag can alleviate a late budding defect imposed by
proteasome inhibitors or functionally replace a YPDL L-domain
[44,48]. However, this study is the first to demonstrate that
ubiquitin can act synergistically with a PTAP motif, resulting in
dramatically enhanced particle release when both are present.
Moreover, the ability of fused ubiquitin to stimulate budding
became evident at significantly lower Gag-ubiquitin abundance
(5% to 25% of total Gag) when a PTAP motif was also present in
Gag. Since ubiquitin could serve as an additional docking site for
Tsg101, it might synergize with PTAP motifs by increasing the
overall affinity of the assembling Gag lattice for individual
ESCRT-I complexes. In fact, this property was predicted by
previous binding studies involving Tsg101 UEV domain, PTAP
containing peptides and ubiquitin [7]. Ubiquitin might also
synergize with PTAP motifs by providing binding sites for distinct
class E VPS factors (e.g. ALIX), thereby optimally utilizing all the
available components of the ESCRT machinery. Consistent with
these ideas, PTAP and PPxY L-domains behaved synergistically in
driving particle release, as did PTAP and Gag-fused ubiquitin.
However, a PPxY motif and Gag-fused ubiquitin behaved
redundantly, consistent with the notion that that they ultimately
function through the same mechanism.
Materials and Methods
Plasmid construction
pCAGGS-based expression plasmids encoding Lck-Gag(PSAP),
Lck-Gag(L-), Lck-Gag-PY, and Lck-Gag-PY-3K plasmids have
been described previously [29]. The Lck-Gag(ASAP) plasmid was
derived from Lck-Gag(PSAP) by PCR-based site-directed muta-
genesis. The Lck-Gag(PSAP)-PY plasmid was generated by
replacement of a StuI/XhoI fragment from the Lck-Gag(PSAP)
plasmid with the corresponding fragment from the Lck-Gag-PY
plasmid. cDNAs expressing Lck-Gag-Ub (ubiquitinDGG) fusion
proteins were generated by overlap-extension PCR, using
pCAGGs-Lck-Gag(PSAP), Lck-Gag(L-), and Lck-Gag(PSAP)-PY
as templates for the N-terminal portions and pHA-ubiquitin as the
template for the C-terminal portion. The K48R, K63R, F4A, L8A,
I44A, and QE62,64AA point mutations were introduced into the
Lck-Gag-Ub construct by PCR-based mutagenesis. Each cDNA
was cloned into pCAGGs for expression in mammalian cells.
DNAs encoding the HECT domains from WWP1 (residues
543–922), WWP2 (491–870), Nedd4 (520–902), Nedd4L (593–
975), Itch (483–862), Smurf1 (374–757), and Rsp5 (431–809) were
amplified from plasmids encoding the full-length HECT ligases
[17,58]. The Bul2 HECT domain (encoding residues 1189–1572)
was PCR amplified from 293T cell cDNA. The catalytically
inactive WWP1 HECT domain (C890S) was amplified from a
previously described full-length mutant WWP1 ligase [17].
Catalytic point mutants of the remaining HECT domains were
made by PCR-based mutagenesis. Chimeric ubiquitin ligases,
comprising the C2 and WW domains (residues 1–542) of WWP1
and each of the HECT domains described above were generated
by overlap PCR. Likewise, plasmids expressing Tsg-WWP1, Tsg-
Nedd4L and Tsg-Itch (residues 1–157 of Tsg101 fused to HECT
domains of WWP1, Nedd4L, or Itch) as well as WWP1-Tsg-C
(residues 1–542 of WWP1 fused to residues 157–390 of Tsg101)
were constructed by overlap-extension PCR. All cDNAs encoding
chimeric proteins were inserted into pCR3.1/YFP, to express
proteins fused to the C-terminus of YFP, for in mammalian cells.
The class E VPS factor yeast two-hybrid library and plasmids
expressing Vps4 E228Q, Tsg101, Hrs, ALIX, UBPY, and Eap45
fluorescent fusion proteins in mammalian cells have been
described previously [8,12,54]. Yeast two-hybrid plasmids encod-
ing wild type and I44A mutant ubiquitin were constructed by PCR
amplification of ubiquitinDGG from the pHA-ubiquitin plasmid
using 59 and 39 primers appended with EcoRI restriction sites and
cloning into the pGBKT7 (Clontech) and pVP16 vectors [8].
Virus release assays
For Gag particle release assays, 5610
5 293T cells in six-well
plates were transfected using polyethylenimine (Polysciences) with
or fusion to Gag. These studies suggest that ubiquitin functions like a transferable L-domain, recruiting class E VPS factors such as ESCRT-I and ALIX,
independently of the identity if the protein to which it is attached.
doi:10.1371/journal.ppat.1001153.g009
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pCR3.1/YFP, pCR3.1/YFP-WWP1/HECT, pCR3.1/YFP-Tsg-
HECT, or pCR3.1/YFP-C2-WW-Tsg-C plasmids, or the indi-
cated amounts of pCR3.1/YFP-Vps4 E228Q plasmid. For EIAV
and MLV VLP release assays, 293T cells were transfected in the
same format with 500ng of, pCR3.1/EIAVGag or pCR3.1/
MLVGag-HA plasmids. VLPs were pelleted by ultracentrifugation
of 2 ml of 0.22-mm-filtered culture supernatants, collected
48 hours after transfection, over a 2ml 20% sucrose cushion for




5) in six-well plates were cotransfected with
1 mg of pCAGGs/Lck-Gag-PY-3K, 500 ng of pHA-ubiquitin, and
1 mg of the indicated chimeric pCR3.1-WWP1-HECT ligase. At
36h after transfection, cells were thoroughly lysed at room
temperature in detergent-rich RIPA buffer (50mM Tris pH 7.4,
150mM NaCl, 1mM EDTA, 1.0% glycerol, 0.5% SDS,
supplemented with protease inhibitor tablets (Roche) and 5mM
N-ethylmaleimide to inhibit deubiquitination) and cleared of
cellular debris by microcentrifugation. The lysates were then
diluted 5-fold in the same buffer containing NP-40 rather than
SDS, to adjust the concentration of SDS to 0.1% and NP-40 to
1.0%, and split into two fractions. From one fraction, Gag proteins
were immunoprecipitated with aPFV serum and protein G-
Sepharose beads. From the other fraction, YFP-HECT ligase
proteins were immunoprecipitated with aGFP monoclonal
antibody and protein G-Sepharose beads. Immunoprecipitates
and unfractionated cell lysates were analyzed by Western blotting.
siRNA transfections
293T cells (3610
5) in six-well plates were transfected with
siGENOME siRNAs targeting Luciferase, Tsg101, Hrs, Alix,
UBPY, or Eap45 (Dharmacon) using Lipofectamine 2000
(Invitrogen). After 24h, cells were transfected with the same
siRNAs and the indicated Gag expression plasmids. VLP and cell
lysates were prepared 48 h after the second transfection. To assess
knockdown efficiency, 293T cells were transfected once with YFP-
Tsg101, -Hrs, -ALIX, -UBPY, or -Eap45 expression plasmids and
corresponding siRNAs. GFP expression in cell lysates harvested
48 h after transfection was assayed by quantitative Western
blotting.
Western blot analyses
Virion and cell lysates and immunoprecipitates were separated
on polyacrylamide gels, transferred to nitrocellulose membranes,
and probed with various antibodies: anti-PFV human serum, anti-
HIV-1 p24CA (183-H12-5C), anti-EIAV equine serum (VMRD,
Inc.), anti-GFP (Roche), and anti-HA (HA.11, Covance) anti-
Tsg101 (4A10, Abcam, Cambridge, MA) or anti-ALIX rabbit
serum (a gift from Wes Sundquist). Subsequently, the blots were
probed with species-specific peroxidase-conjugated secondary
antibodies and chemiluminescent substrate reagents. Alternatively,
for quantitative Western blotting, membranes were probed with
species-specific antibodies conjugated to IRDye800CW, and
fluorescent signals were detected and quantified using a LICOR
Odyssey scanner.
Yeast two-hybrid analyses
Yeast cells (Y190) were transformed with the pGBKT7- and
pVP16-derived plasmids described above. Transformants were
selected and protein-protein interactions were assayed by b-
galactosidase reporter activity as previously described [8].
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